October 01, 2016 2:47 PM ET

Biotechnology

Company Overview of aTyr Pharma Inc.

Key Executives for aTyr Pharma Inc.

NameBoard RelationshipsTitleAge
John D. Mendlein Ph.D., J.D.81 RelationshipsChief Executive Officer and Director56
Paul R. Schimmel Ph.D.90 RelationshipsFounder, Director and Member of Compensation Committee75
Xiang-Lei Yang Ph.D.No RelationshipsFounder--
John T. Blake CPANo RelationshipsVice President of Finance40
David J. King Ph.D.No RelationshipsSenior Vice President of Research--
View More Key Executives

aTyr Pharma Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John K. Clarke 75 RelationshipsAlnylam Pharmaceuticals, Inc.62
John D. Mendlein Ph.D., J.D. 81 RelationshipsaTyr Pharma Inc.56
Paul R. Schimmel Ph.D. 90 RelationshipsaTyr Pharma Inc.75
James C. Blair Ph.D. 164 RelationshipsDomain Associates, L.L.C.76
Kathryn E. Falberg 54 RelationshipsThe Trade Desk, Inc.55
View All Board Members

aTyr Pharma Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Kathryn E. Falberg54 Relationships2 Executives
Compensation Committee Ph.D.James C. Blair164 Relationships3 Executives
Nominating Committee John K. Clarke75 Relationships2 Executives
Corporate Governance Committee John K. Clarke75 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$472.8K
472.8K
382.5K
Bonus
Not meaningful
Total Short Term Compensation$472.8K
472.8K
477.4K
Total Value of Options
32.9M
Compensation as of Fiscal Year
aTyr Pharma Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Heron Therapeutics, Inc. Announces the Resignations of Management Members
September 30, 2016 9:17 PM ET
Avagenesis Corp. Appoints Colin Chen as an Advisor
September 30, 2016 9:00 PM ET
Chiasma, Inc. Announces Management Changes
September 30, 2016 8:15 PM ET
Medibio Limited Announces Resignation of James Campbell as Non-Executive Director
September 30, 2016 3:22 AM ET
Threshold Pharmaceuticals Inc. to Implement Workforce Reduction; Announces Resignation of Stewart Kroll as Chief Operating Officer
September 29, 2016 9:20 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact aTyr Pharma Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.